Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP569897.RAKg48-f40WO0S_sjLrAJQG8JTzyPIfsLbzXOzOL-ibzU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP569897.RAKg48-f40WO0S_sjLrAJQG8JTzyPIfsLbzXOzOL-ibzU130_assertion type Assertion NP569897.RAKg48-f40WO0S_sjLrAJQG8JTzyPIfsLbzXOzOL-ibzU130_head.
- NP569897.RAKg48-f40WO0S_sjLrAJQG8JTzyPIfsLbzXOzOL-ibzU130_assertion description "[Highly invasive human prostate cancer cells PC-3 were treated with either the methyl donor S-adenosylmethionine (SAM) or methyl DNA-binding domain protein 2 antisense oligonucleotide (MBD2-AS).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP569897.RAKg48-f40WO0S_sjLrAJQG8JTzyPIfsLbzXOzOL-ibzU130_provenance.
- NP569897.RAKg48-f40WO0S_sjLrAJQG8JTzyPIfsLbzXOzOL-ibzU130_assertion evidence source_evidence_literature NP569897.RAKg48-f40WO0S_sjLrAJQG8JTzyPIfsLbzXOzOL-ibzU130_provenance.
- NP569897.RAKg48-f40WO0S_sjLrAJQG8JTzyPIfsLbzXOzOL-ibzU130_assertion SIO_000772 16982764 NP569897.RAKg48-f40WO0S_sjLrAJQG8JTzyPIfsLbzXOzOL-ibzU130_provenance.
- NP569897.RAKg48-f40WO0S_sjLrAJQG8JTzyPIfsLbzXOzOL-ibzU130_assertion wasDerivedFrom befree-2016 NP569897.RAKg48-f40WO0S_sjLrAJQG8JTzyPIfsLbzXOzOL-ibzU130_provenance.
- NP569897.RAKg48-f40WO0S_sjLrAJQG8JTzyPIfsLbzXOzOL-ibzU130_assertion wasGeneratedBy ECO_0000203 NP569897.RAKg48-f40WO0S_sjLrAJQG8JTzyPIfsLbzXOzOL-ibzU130_provenance.